Comparative Pharmacology
Head-to-head clinical analysis: MICONAZOLE 7 COMBINATION PACK versus SELSUN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MICONAZOLE 7 COMBINATION PACK versus SELSUN.
MICONAZOLE 7 COMBINATION PACK vs SELSUN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Miconazole is an imidazole antifungal agent that inhibits the synthesis of ergosterol, a key component of fungal cell membranes, by inhibiting the enzyme lanosterol 14α-demethylase. This leads to increased membrane permeability and leakage of cellular contents, resulting in fungal cell death.
Selenium sulfide is an antifungal agent that inhibits the growth of Malassezia species by reducing selenium to elemental selenium, which is toxic to the fungus. It also reduces sebum production via unknown mechanisms.
Miconazole 200 mg vaginal suppository once daily at bedtime for 7 days, plus miconazole 2% cream applied intravaginally once daily at bedtime for 7 days.
Apply 5-10 mL of 2.5% selenium sulfide lotion to affected areas of scalp, lather with water, leave on for 2-3 minutes, then rinse thoroughly. Use twice weekly for 2 weeks, then once weekly for maintenance.
None Documented
None Documented
Terminal elimination half-life is approximately 24-30 hours after systemic absorption. Clinically, this supports once-daily dosing for the vaginal route.
Not well defined due to minimal systemic absorption; topical application yields negligible plasma levels.
Miconazole is primarily metabolized in the liver, with metabolites and unchanged drug excreted in feces (50-70%) and urine (10-20%). Biliary excretion is a minor route.
Selenium sulfide is minimally absorbed; absorbed portions are excreted renally (approx. 80-90%) and fecally (10-20%).
Category A/B
Category C
Antifungal
Antifungal/Antiseborrheic